Karyopharm Therapeutics Inc. - Common Stock (KPTI)

9.5200
+0.4200 (4.62%)
NASDAQ· Last Trade: Jun 17th, 11:25 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026